A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia

Clinical trial NCT07028073 · RECRUITING

Trial details

NCT number: NCT07028073
Sponsor: The First Affiliated Hospital of Soochow University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia With T(8;21)(Q22;Q22)Acute Myeloid Leukemia With T(16;16)(P13;Q22)KIT Gene Mutation Avapritinib

Start date: 2025-05-15
Primary completion: 2027-05-15
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.